Publications by authors named "Craig B Davis"

Claim this Profile
B
Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.
Thomas Powles, Srikala S Sridhar, Joaquim Bellmunt, Cora N Sternberg, Petros Grivas, Craig B Davis

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.
David S Hong, Ajay K Gopal, Alexander N Shoushtari, Sandip P Patel, Aiwu R He, Craig B Davis

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.
Thomas Powles, Srikala S Sridhar, Yohann Loriot, Joaquim Bellmunt, Xinmeng Jasmine Mu, Craig B Davis

Nat Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 Non-Hodgkin Lymphomas.
Ajay K Gopal, Ronald Levy, Roch Houot, Sandip P Patel, Leslie Popplewell, Craig B Davis

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard machine learning approaches outperform deep representation learning on phenotype prediction from transcriptomics data.
Aaron M Smith, Jonathan R Walsh, John Long, Craig B Davis, Peter Henstock

BMC Bioinformatics· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
Ezra E W Cohen, Michael J Pishvaian, Dale R Shepard, Ding Wang, Jared Weiss, Craig B Davis

J Immunother Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer.
Neil H Segal, Aiwu R He, Toshihiko Doi, Ronald Levy, Shailender Bhatia, Craig B Davis

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocytokines: amplification of anti-cancer immunity.
Craig B Davis, Stephen D Gillies

Cancer Immunol Immunother· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis